PNEUMOSTEM®
2025-10-080
Phase 1 mab active
Quick answer
PNEUMOSTEM® for Pulmonary Arterial Hypertension (PAH) is a Phase 1 program (mab) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Samsung Bioepis NL B.V.
- Indication
- Pulmonary Arterial Hypertension (PAH)
- Phase
- Phase 1
- Modality
- mab
- Status
- active